14.00 1. LONG-TERM SAFETY OF ANTIFIBROTIC DRUGS IN IPF: A REAL-WORLD EXPERIENCE
Stefano Levra, Giuseppe Guida, Andrea E. Sprio, Flavio Crosa, Paolo C. Ghio, Francesca Bertolini, Vitina Carriero, Carlo Albera and Fabio L. M. Ricciardolo Orbassano, Torino - Italy

14.09 2. PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS CAN IMPROVE WITH ANTIFIBROTIC DRUGS? RESULTS FROM A RETROSPECTIVE STUDY
Inas Awad, Antonella Caminati, Roberto Cassandro, Davide Elia, Francesco Mozzanica, Maurizio Zompatori and Sergio Harari Milano- Italy

14.18 3. SHORT-TERM EVOLUTION OF NUTRITIONAL STATUS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
Giovanni Franco, Paola Faverio, Alessia Fumagalli, Sara Conti, Fabiana Madotto, Francesco Bini, Sergio Harari, Michele Mondoni, Tiberio Oggionni, Emanuela Barisione, Paolo Ceruti, Maria Chiara Papetti, Bruno Dino Bodini, Antonella Caminati, Angela Valentino, Stefano Centanni, Paola Lanzi,Matteo Della Zoppa, Silvia Crotti, Marco Grosso, Samir Giuseppe Sukkar, Denise Modina, Marco Andreoli, Roberta Nicali, Giulia Suigo, Sara Busnelli, Giuseppe Paciocco, Sara Lettieri, Lorenzo Giovanni Mantovani, Giancarlo Cesana, Alberto Pesci, Fabrizio Luppi Monza, Casatenovo, Milano, Garbagnate, Pavia, Brescia, Genova - Italy

14.27 4. EXTRACELLULAR VESICLES PROFILE IN BRONCHOALVEOLAR LAVAGE FROM IPF, HP AND SARCOIDOSIS PATIENTS: A MULTICENTER STUDY
Miriana d’Alessandro, Sara Gangi, Piera Soccio, Elisabet Cantó, Ruben Osuna, Laura Bergantini, Paolo Cameli, Gaia Fabbri, Sara Croce, Giulia Scioscia, Giusy Montuori, Matteo Fanetti, Fabrizio Mezzasalma, Diego Castillo, Donato Lacedonia, Silvia Vidal, Elena Bargagli
Siena, Foggia - Italy and Barcelona, Spain

14.36 5. RADIOLOGIC – PATHOLOGIC CORRELATION IN 2-YEAR FOLLOW UP PATIENTS AFTER SARSCOV-2 INFECTION
Cozzi Diletta, Cavigli Edoardo, Luvarà Silvia, Moroni Chiara, Bindi Alessandra, Gori Leonardo, Luzzi Valentina, Pasini Valeria, Comin Camilla Eva, Tomassetti Sara, Miele Vittorio Firenze - Italy

14.45 6. CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE CELLS IN PATIENTS WITH POST COVID-19 PULMONARY SEQUELAE
Eirini Vasarmidi, Eliza Tsitoura, Irini Lambiri, Christos Skiadas, Eleni Bibaki, Nicoleta Bizymi, Andreas Matthaiou, Nikolaos Tzanakis, Katerina Antoniou Crete - Greece

14.54 7. STUDY OF THE EPIDEMIOLOGICAL PROFILE OF PULMONARY HYPERTENSION IN A PULMONARY HYPERTENSION UNIT IN ALGIERS
N. Djami, S. Souilah, R. Amrane, A. Fissah Algeria

15.03 8. SAFETY/EFFICACY OF RT234 VARDENAFIL INHALATION POWDER ON EXERCISE PARAMETERS IN PULMONARY ARTERIAL HYPERTENSION: PHASE 2 DOSE-ESCALATION STUDY DESIGN
Carol Satler, Raymond L. Benza, Veronica Franco, Mandar A. Aras, Leslie Spikes, Daniel Grinnan Boston, MA, USA - Columbus, OH, USA - San Francisco, CA, USA - Kansas City, KS, USA - Richmond, VA, USA

15.12 9. BENRALIZUMAB EFFECTS MODULATE NK CELL MATURATION, PROLIFERATION, AND ACTIVATION IN SEVERE ASTHMATIC PATIENTS
Laura Bergantini, Miriana d’Alessandro, Tommaso Pianigiani, Elena Bargagli, Paolo Cameli Siena - Italy

15.21 10. PI*ZQ0ATTIKON GENOTYPE DEBUT IN ALPHA-1 ANTITRYPSIN DEFICIENCY
Spyros A. Papiris, Martina Veith, Aggeliki Lazaratou, Malika Balduyck, Christine Lombard, Magali Dechomet, Marie-Françoise Odou, Maria Kallieri, Vasiliki Apollonatou, Lykourgos Kolilekas, Ilaria Ferrarotti, Jean-François Mornex, Claus-Franz Vogelmeier, Timm Greulich, Effrosyni D Manali Athens - Greece, Marburg - Germany, Lille and Lyon- France, Pavia - Italy